60
Participants
Start Date
December 1, 2020
Primary Completion Date
December 1, 2024
Study Completion Date
December 1, 2024
Argon-Helium Cryoablation
Procedure performed within 7 days before the first dose of PD-1 inhibitor. CT-guided insertion of cryoprobes into the target tumor. Two freeze-thaw cycles: rapid freeze to -135°C to -145°C for 15-20 minutes, followed by thawing.
Camrelizumab
200 mg intravenously every 3 weeks for 4 cycles.
Platinum-based doublet chemotherapy
"* Non-squamous NSCLC: Pemetrexed (500 mg/m² IV on day 1) plus Carboplatin (AUC 5 mg/mL•min IV on day 1) of each 3-week cycle.~* Squamous NSCLC: Gemcitabine (1250 mg/m² IV on days 1 and 8) plus Carboplatin (AUC 5 mg/mL•min IV on day 1) of each 3-week cycle.~* Administered for 4 cycles."
the First Hospital of Hebei Medical University, Shijiazhuang
The First Hospital of Hebei Medical University
OTHER